Avedro, ACOS commence accelerated corneal cross-linking Phase 3 study
ACOS and Avedro, Inc. jointly announced today the initiation of a Phase 3, multi-center, randomized, controlled evaluation to study accelerated corneal collagen cross-linking in eyes with keratoconus or corneal ectasia after refractive surgery.